PHARMAVERSITY

LIVE

Serial Number

79358754

Owner

SCHOTT Pharma AG & Co. KGaA

Filing Date

Jul 25, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

PHARMAVERSITY Trademark

Serial Number: 79358754 • Registration: 7209722

PHARMAVERSITY is a trademark filed by SCHOTT Pharma AG & Co. KGaA on July 25, 2022. The trademark is classified under Class 41 (Education & Entertainment). The application is currently registered and active.

Trademark Classes

Class 41 - Education & Entertainment

Education; providing of training; entertainment; sporting and cultural activities

Owner Contact Info

SCHOTT Pharma AG & Co. KGaA (12 trademarks)

Hattenbergstrasse 10

Entity Type: 99

SCHOTT AKTIENGESELLSCHAFT (91 trademarks)

10 HATTENBERGSTRASSE
D-55122 MAINZ 55122 , DE

Entity Type: 09

Legal Representation

Correspondence Address

Ann K. Ford DLA Piper LLP (SU)

500 8th St. NW

Washington

DC 20004

UNITED STATES

Trademark Details

Filing Date

July 25, 2022

Registration Date

November 7, 2023

Published for Opposition

August 22, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB

Mar 4, 2024 FINO

FINAL DISPOSITION NOTICE SENT TO IB

Feb 12, 2024 FICS

FINAL DISPOSITION PROCESSED

Feb 12, 2024 FIMP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Feb 7, 2024 FICR

CHANGE OF OWNER RECEIVED FROM IB

Dec 22, 2023 CHLD

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Nov 7, 2023 NRCC

REGISTERED-PRINCIPAL REGISTER

Nov 7, 2023 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 22, 2023 NPUB

PUBLISHED FOR OPPOSITION

Aug 22, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 2, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 20, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 19, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 18, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 18, 2023 TROA

REFUSAL PROCESSED BY IB

Jul 11, 2023 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jun 19, 2023 RFCS

REFUSAL PROCESSED BY MPU

Jun 19, 2023 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

May 13, 2023 RFCR

NON-FINAL ACTION WRITTEN

May 12, 2023 CNRT

ASSIGNED TO EXAMINER

May 11, 2023 DOCK

APPLICATION FILING RECEIPT MAILED

Jan 7, 2023 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 3, 2023 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Dec 29, 2022 REPR

Related Trademarks

More from this Owner

SYRIQ XLINK

SYRIQ BIOPURE XLINK

D 263

PHARMAVERSITY

More in Same Class

9 CRYSTAL BONANZA